Open Access
Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis
Shoujiang You, Anubhav Saxena, Xia Wang, WeeYong Tan, Qiao Han, Yongjun Cao, Chun-Feng Liu
DOI: 10.1136/svn-2017-000106 Published 22 March 2018
Shoujiang You
1
Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, China
Anubhav Saxena
2
The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia
Xia Wang
2
The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia
WeeYong Tan
3
Department of Neurology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
Qiao Han
4
Department of Neurology, Suzhou Hospital of Traditional Chinese Medicine, Suzhou, China
Yongjun Cao
1
Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, China
5
Institutes of Neuroscience, Soochow University, Suzhou, China
Chun-Feng Liu
1
Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, China
5
Institutes of Neuroscience, Soochow University, Suzhou, China

Submit a Response to This Article
No eLetters have been published for this article.
Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis
Shoujiang You, Anubhav Saxena, Xia Wang, WeeYong Tan, Qiao Han, Yongjun Cao, Chun-Feng Liu
Stroke and Vascular Neurology Mar 2018, 3 (1) 22-27; DOI: 10.1136/svn-2017-000106

Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis
Shoujiang You, Anubhav Saxena, Xia Wang, WeeYong Tan, Qiao Han, Yongjun Cao, Chun-Feng Liu
Stroke and Vascular Neurology Mar 2018, 3 (1) 22-27; DOI: 10.1136/svn-2017-000106